Changes to our trading names and address – MSD and Organon & Co. read more

Changes to our trading names and address

Please note that in 2021, MSD will be spinning off products from its women’s health, legacy brands, and biosimilars franchises into a new independent, publicly traded company known as Organon & Co.

Due to legal entity separation in advance of this spin off, we now have two UK registered businesses, MSD and Organon. Organon & Co. is a wholly owned subsidiary of Merck & Co., Inc. of Kenilworth, New Jersey, USA.

As a result of the future spin-off of Organon, as well as our head offices moving to London in early 2021, you will begin to see some changes to references to our products, contact details, materials and statements over the coming months.


Vaccine products
supply status

MSD vaccines are supplied through our designated wholesaler, AAH Pharmaceuticals Ltd. If you do not currently have an account, you will need to set one up.

For more information or to set up an account, please contact:

 

AAH Customer Care

0344 561 8899

 

Visit the website

www.aah.co.uk

 

This page is intended for use by UK healthcare professionals only. Trademarks appearing on this website are owned, licensed to, promoted or distributed by Merck & Co., Inc., Kenilworth, NJ, USA, its subsidiaries or affiliates, except as noted.

Job code: GB-NON-03518Date of preparation: November 2020